Consigue una respuesta de este empleador
Tu currículum y tu carta de presentación, adaptados exactamente a lo que buscan contratar.
Prudentia Sciences in Dublin, Ireland is seeking a Director of Customer Success to manage a portfolio of Top 25 biopharma accounts, owning the commercial outcomes from onboarding through renewal. You will drive platform adoption, retention and expansion, translate customer feedback into product roadmaps, and collaborate with Product, Engineering, Sales and Scientific teams to maximize value.
The role requires 8+ years in customer success or related fields in life sciences, with strong executive
Prudentia Sciences is the scientific intelligence layer powering life sciences dealmaking. We bring together expert-developed scientific diligence frameworks, AI reasoning trained on drug development, and a unified evidence base to accelerate investment in breakthrough therapies. As a trusted third party operating between buyer and seller, we help build conviction through every stage of the deal, faster. We replace fragmented workflows with a single system that surfaces what matters earlier.
Backed by GV (Google Ventures), McKesson, Iaso Ventures, Virtue, and SignalFire - and built by people who have sat on every side of the table in life sciences dealmaking - we're on a mission to bring expert scientific judgment to every deal decision, at AI scale.
We're looking for a Director of Customer Success to manage and scale a portfolio of strategic biopharma accounts. You'll own commercial outcomes for Top 25 biopharma customers, driving platform adoption, retention, and expansion to build a “business within the business”. Customer feedback from your portfolio will directly inform our product roadmap and operating model. You’ll operate with the judgment of an owner, not just execute a playbook.
Compensation Range: $170K - $200K
Prudentia Sciences is the scientific intelligence layer powering life sciences dealmaking. We bring together expert-developed scientific diligence frameworks, AI reasoning trained on drug development, and a unified evidence base to accelerate investment in breakthrough therapies. As a trusted third party operating between buyer and seller, we help build conviction through every stage of the deal, faster. We replace fragmented workflows with a single system that surfaces what matters earlier.
Backed by GV (Google Ventures), McKesson, Iaso Ventures, Virtue, and SignalFire - and built by people who have sat on every side of the table in life sciences dealmaking - we're on a mission to bring expert scientific judgment to every deal decision, at AI scale.